13F filer · CIK 19617 ↗
Jpmorgan Chase & Co
You are looking at Q1 2022. See the latest, Q2 2026 →
Reported value
$830.28B
−4.1% on the quarter before
Positions
6,720
732 new · 803 sold out
Top 10
17.5%
of the value
Est. gain
−$38.37B
on stocks held all quarter
Est. return
−5.2%
on those stocks since Q4 2021
Positions as of Mar 31, 2022, from Jpmorgan Chase & Co's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 27% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2021. Striped tiles are options.
Largest buys
Since Q4 2021, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- SPDR S&P 500 ETF TrPUT~$4.64BAdded · 0.6% → 1.1%+10,276,700 underlying
- Vanguard Total Bond Market~$2.22BAdded · 0.2% → 0.5%+27,984,408 shares
- Jpmorgan Betabuilders Europe ETF~$2.05BAdded · 1.0% → 1.2%+37,325,835 shares
- Abbvie Inc~$1.78BAdded · 0.7% → 1.1%+10,989,210 shares
- Vanguard Total Intl Bond ETF~$1.63BAdded · 1.0% → 1.2%+31,041,322 shares
- Exxon Mobil Corp~$1.60BAdded · 0.1% → 0.3%+19,338,645 shares
- S&P Global Inc~$1.07BAdded · 0.2% → 0.3%+2,610,083 shares
- Ishares TrPUT~$883.0MAdded · 0.1% → 0.2%+7,191,800 underlying
- Ishares TrPUT~$869.9MAdded · 0.1% → 0.2%+10,571,200 underlying
- Vanguard Long-Term Treasury ETF~$789.0MAdded · 0.0% → 0.1%+9,813,317 shares
Largest sells
Since Q4 2021, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Vanguard Short-Term Bond ETF~$3.92BCut · 0.8% → 0.3%−50,325,520 shares
- SPDR S&P 500 ETF Trust~$1.35BCut · 3.3% → 3.2%−2,997,228 shares
- Tesla~$1.22BCut · 0.9% → 0.9%−1,128,797 shares
- Vanguard Short-Term Treasury Index Fund~$1.13BCut · 0.4% → 0.3%−19,058,579 shares
- Ishares Tips Bond ETF~$1.03BCut · 0.1% → 0.0%−8,241,272 shares
- AmazonPUT~$889.0MCut · 0.2% → 0.1%−272,700 underlying
- Schwab Short-Term Us Treas~$840.8MCut · 0.2% → 0.1%−16,971,214 shares
- Technology Select Sect SPDR~$840.3MCut · 0.1% → 0.0%−5,286,915 shares
- Ishares TrPUT~$763.2MCut · 0.5% → 0.4%−4,822,500 underlying
- Ishares 1-3 Year Treasury Bo~$729.0MCut · 0.2% → 0.1%−8,746,311 shares
Holdings
As of Mar 31, 2022. Changes are in shares against Dec 31, 2021, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SPDR S&P 500 ETF TrustFUND · shares −4.9% · price −4.9% | 3.2% | $26.22B | −$1.35B | ||||||||
| MicrosoftCOMMON · shares −1.6% · price −8.3% | 3.1% | $25.47B | −$2.31B | ||||||||
| AppleCOMMON · shares +1.7% · price −1.7% | 2.7% | $22.13B | −$369.0M | ||||||||
| AmazonCOMMON · shares −1.4% · price −2.2% | 1.8% | $14.79B | −$337.5M | ||||||||
| AlphabetCOMMON · shares +0.2% · price −3.5% | 1.3% | $10.50B | −$377.5M | ||||||||
| Jpmorgan Betabuilders Europe ETFFUND · shares +25% · price −8.1% | 1.2% | $10.22B | −$723.8M | ||||||||
| Vanguard Total Intl Bond ETFFUND · shares +20% · price −4.9% | 1.2% | $9.57B | −$411.9M | ||||||||
| SPDR S&P 500 ETF TrPUTOPTION · shares +97% | 1.1% | $9.40B | — | ||||||||
| Abbvie IncCOMMON · shares +25% · price +19.7% | 1.1% | $8.77B | +$1.15B | ||||||||
| Unitedhealth Group IncCOMMON · shares +5.9% · price +1.6% | 1.0% | $8.55B | +$123.8M | ||||||||
| AlphabetCOMMON · shares +0.03% · price −4.0% | 0.94% | $7.79B | −$323.8M | ||||||||
| TeslaCOMMON · shares −15% · price +2.0% | 0.85% | $7.07B | +$136.6M | ||||||||
| Bristol-Myers Squibb CoCOMMON · shares +2.3% · price +17.1% | 0.83% | $6.86B | +$979.9M | ||||||||
| MastercardCOMMON · shares −1.4% · price −0.5% | 0.73% | $6.03B | −$32.7M | ||||||||
| Jpmorgan Betabuilders Japan ETFFUND · shares +6.1% · price −7.9% | 0.71% | $5.93B | −$477.8M | ||||||||
| Deere & CoCOMMON · shares +4.0% · price +21.2% | 0.69% | $5.73B | +$962.4M | ||||||||
| Jpmorgan Betabuilders CanadaFUND · shares +2.4% · price +4.4% | 0.68% | $5.65B | +$231.3M | ||||||||
| Nextera Energy IncCOMMON · shares +6.5% · price −9.3% | 0.66% | $5.50B | −$527.2M | ||||||||
| Bk Of America CorpCOMMON · shares +16% · price −7.3% | 0.63% | $5.23B | −$356.9M | ||||||||
| Texas InstrumentsCOMMON · shares +12% · price −2.6% | 0.61% | $5.08B | −$123.8M | ||||||||
| NvidiaCOMMON · shares −7.4% · price −7.2% | 0.61% | $5.04B | −$392.6M | ||||||||
| ConocophillipsCOMMON · shares −5.8% · price +38.5% | 0.58% | $4.80B | +$1.34B | ||||||||
| Eli LillyCOMMON · shares −4.1% · price +3.7% | 0.56% | $4.67B | +$165.4M | ||||||||
| Johnson & JohnsonCOMMON · shares −9.7% · price +3.6% | 0.55% | $4.59B | +$159.6M | ||||||||
| PrologisCOMMON · shares −1.8% · price −4.1% | 0.55% | $4.58B | −$195.0M | ||||||||
| Total · 6,720 positions | 100% | $830.28B | −$38.37B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2021 to Q1 2022: 4,945 stocks held throughout, down $38.37B (−5.2%).
- Conocophillips+$1.34B+39%
- Abbvie Inc+$1.15B+20%
- Chevron Corp New+$1.01B+39%
- Bristol-Myers Squibb Co+$979.9M+17%
- Deere & Co+$962.4M+21%
- Sea−$1.06B−46%
- AMD−$1.34B−24%
- SPDR S&P 500 ETF Trust−$1.35B−5%
- Meta−$2.07B−34%
- Microsoft−$2.31B−8%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 47 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $1.81T+16% | SEC ↗ |
| Q1 2026 | May 13, 2026 (amended) | $1.56T−2% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $1.59T−52% | SEC ↗ |
| Q3 2025 | Nov 7, 2025 (amended) | $3.34T+118% | SEC ↗ |
| Q2 2025 | Aug 12, 2025 | $1.53T+12% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $1.37T+2% | SEC ↗ |
| Q4 2024 | Feb 12, 2025 | $1.34T−49% | SEC ↗ |
| Q3 2024 | Nov 8, 2024 (amended) | $2.63T+8% | SEC ↗ |
| Q2 2024 | Aug 12, 2024 (amended) | $2.44T+3% | SEC ↗ |
| Q1 2024 | May 10, 2024 (amended) | $2.37T+14% | SEC ↗ |
| Q4 2023 | Feb 12, 2024 (amended) | $2.08T+130% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $906.36B−2% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $920.27B+12% | SEC ↗ |
| Q1 2023 | May 18, 2023 (amended) | $820.88B+8% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $758.55B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $696.38B−3% | SEC ↗ |
| Q2 2022 | Aug 11, 2022 | $717.86B−14% | SEC ↗ |
| Q1 2022 | May 11, 2022 | $830.28B−4% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 (amended) | $865.90B+7% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $808.68B−4% | SEC ↗ |
| Q2 2021 | Aug 12, 2021 | $838.21B+12% | SEC ↗ |
| Q1 2021 | May 12, 2021 | $749.21B+10% | SEC ↗ |
| Q4 2020 | Feb 19, 2021 (amended) | $680.63B+14% | SEC ↗ |
| Q3 2020 | Nov 12, 2020 (amended) | $595.09B+15% | SEC ↗ |
| Q2 2020 | Aug 11, 2020 | $518.17B+22% | SEC ↗ |
| Q1 2020 | May 12, 2020 | $425.90B−21% | SEC ↗ |
| Q4 2019 | Feb 11, 2020 | $536.28B+7% | SEC ↗ |
| Q3 2019 | Nov 12, 2019 | $502.15B−2% | SEC ↗ |
| Q2 2019 | Aug 7, 2019 | $511.43B+4% | SEC ↗ |
| Q1 2019 | May 7, 2019 | $489.55B+13% | SEC ↗ |
| Q4 2018 | Feb 11, 2019 | $432.49B−17% | SEC ↗ |
| Q3 2018 | Nov 13, 2018 (amended) | $522.20B+7% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $486.35B+4% | SEC ↗ |
| Q1 2018 | May 10, 2018 | $466.55B−2% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $474.64B+5% | SEC ↗ |
| Q3 2017 | Nov 9, 2017 | $453.26B+4% | SEC ↗ |
| Q2 2017 | Aug 9, 2017 | $437.53B−0% | SEC ↗ |
| Q1 2017 | May 10, 2017 | $437.58B+5% | SEC ↗ |
| Q4 2016 | Feb 6, 2017 | $416.17B+2% | SEC ↗ |
| Q3 2016 | Nov 4, 2016 | $406.33B+1% | SEC ↗ |
| Q2 2016 | Aug 8, 2016 | $401.04B+3% | SEC ↗ |
| Q1 2016 | May 10, 2016 | $390.67B | SEC ↗ |